Researchers at Oregon Health & Science University have discovered that the neurotransmitter adenosine effectively acts as a brake to dopamine,
Month: November 2022
New biomarker could help diagnose Alzheimer’s disease early
A definitive diagnosis of Alzheimer’s disease (AD) was once only possible after someone had died, but recent biomarker studies have
Exploring the potential of the seal-like Paro robot in an elderly care setting
In recent years, many roboticists and psychologists have been assessing the value of social robots as companions and assistants for
Alzheimer’s disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates
In Alzheimer’s disease, the degeneration of brain cells is linked to formation of toxic protein aggregates and deposits known as
Toxic cooking fumes cause complications in some pregnant women
Exposure to indoor household pollution has been linked to poor pregnancy outcomes for women in low- and middle-income countries in
Reflecting on neurotechnology as the next frontier of medical treatment
Neurotechnology—the combination of neuroscience and technology—has the potential to both “decode” and shape brain activity, with important implications for future
Genetic variation and the diverse range of behaviors in autism
Research in humans and animal models points to potential biological and genetic mechanisms contributing to the diversity of behaviors seen
Obesity, Parkinson’s disease, and pesticides: Exploring the gut-brain connection
The community of microorganisms living in the human gut, known as the gut microbiome, is increasingly recognized as playing a
How pregnancy changes the parental brain
Pregnancy and birthing have profound, often long-lasting, effects on brain physiology, mood and behavior. New findings on the neurobiology of
Brain changes: Examining the lingering effects of COVID-19
More profoundly than previously believed, the virus that causes COVID-19, SARS-CoV-2, can impact the brain for months after infection. The